| S. Herold / T. Welte† |
Acute Lung Injury |
UGMLC, BREATH |
GI HOPE: Promotion of host defense and alveolar barrier regeneration by inhaled GM-CSF in patients with pneumonia-associated ARDS |
| M. Kreuter / C. Vogelmeier / F. Herth |
COPD |
UGMLC, TLRC |
ExperTENTION: Exploring efficacy of peridontal treatment on systemic inflammation and for prevention of exacerbations in patients with COPD: A multi-center, prospective, randomized, controlled, parallel-group pilot study |
| M. Reck / O. Ammerpohl |
Lung Cancer |
UGMLC |
EMO-Lung: Monitoring of patients with NLCLC – epigenetic analysis of liquid biopsies and RNA-analysis in exhaled breath condensates |
| H. Schulz / S. Meiners / J. Behr / C. Vogelmeier |
COPD |
CPC-M, UGMLC |
PBMC: Proteasom Function as a Bio-Marker for COPD |
| W. Seeger / A. Ghofrani |
Pulmonary Hypertension |
UGMLC |
Right Heart 3: Influence of specific PAH medication on right ventricular function in patients with pulmonary arterial hypertension |
| J. Vogel-Claussen |
Pulmonary Hypertension / Platform Imaging |
BREATH |
Change MRI: Phase III diagnostic trial to demonstrate that functional lung MRI can replace VQ-SPECT in a diagnostic strategy for patients with suspected CTEPH. |
| P. Zabel / F. Herth |
COPD |
ARCN, TLRC |
PLBV: Evaluation of non-invasive pursed-lip breathing ventilation in advanced COPD |
| O. Sommerburg |
Cystic Fibrosis |
TLRC |
ANAKIN: Study to evaluate the safety and efficacy of subcutaneous Administration of Anakinra in patients with cystic fibrosis |
| M. Eichhorn / R. Savai |
Lung Cancer |
TLRC, UGMLC |
Neomun Trial: Neoadjuvant anti PD-1 immunotherapy in resectable NSCLC. |
| J. Behr / P. Mertsch / F. Ringshausen / J. Rademacher |
Bronchiectasis Disease |
CPC-M, BREATH |
Eradicate: Inhaled Levofloxacin in adult bronchiectasis patients with early asymptomatic Pseudomonas aeruginosa infection |
| N. Kneidinger/ A.Ö. Yildirim / M. Hecker |
End-Stage Lung Disease |
CPC-M, UGMLC |
CatBOS: Cathepsin-B (CatB) as a new biomarker and therapeutic target for early bronchiolotis obliterans syndrome (BOS) after lung transplantation |
| J. Vogel-Claussen / S. Bohnet / M. Reck |
Lung Cancer |
BREATH, ARCN |
HANSE Study: Holistic implementation study Assessing a Northern German interdisciplinary lung cancer screening effort |
| S. Herold / T. Welte† |
Acute Lung Injury |
UGMLC, BREATH |
Cyclosporine A: Early intervention treatment of SARS-CoV-2 with liposomal Cyclosporine A for Inhalation (L-CsA-i) in non-hospitalized patients due to Covid 19
|
|
|
|
|
